Roche Holding AG (FRA:RHO5)

Market Cap	260.95B
Revenue (ttm)	67.98B
Net Income (ttm)	10.10B
Shares Out	n/a
EPS (ttm)	12.57
PE Ratio	25.85
Forward PE	14.86
Dividend	9.70 (3.18%)
Ex-Dividend Date	Mar 27, 2025

Volume	224
Average Volume	441
Open	307.50
Previous Close	308.15
Day's Range	300.15 - 307.50
52-Week Range	259.15 - 317.65
Beta	n/a
RSI	53.85
Earnings Date	Oct 20, 2025

About Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagn...

• Industry: Pharmaceutical Preparations
• Founded: 1896
• Employees: 103,249
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: RHO5

Financial Performance

In 2024, Roche Holding AG's revenue was 62.40 billion, an increase of 3.23% compared to the previous year's 60.44 billion. Earnings were 8.28 billion, a decrease of -28.01%.

Financial numbers in CHF